National Conference of the Italian Group for the Study of Neuromorphology
Vol. 70 No. s2 (2026): 36th National Conference of the Italian Group for the Study of...

OC15 | EXPLORING Α-SYNUCLEIN/ACETYLATED Α-TUBULIN INTERPLAY ACROSS DOPAMINERGIC CIRCUITS IN A MOUSE MODEL OF PARKINSON’S DISEASE

M. Tricco1, B. Bonaldo1, A. Pianta1, G. Faustini2, A. Bellucci2, G. Cappelletti1 | 1Department of Biosciences, Università degli Studi di Milano, Italy; 2Department of Molecular and Translational Medicine, University of Brescia, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
0
Views
0
Downloads

Authors

Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder, primarily characterized by the loss of dopaminergic neurons in the substantia nigra (SN) and the formation of α-synuclein (α-Syn)-positive cytoplasmic inclusions termed Lewy bodies. Like other mostly sporadic diseases, PD etiology involves multiple factors, such as genetics, aging, immunity, and environmental exposures. Since its identification as the first autosomal dominant gene for PD, hSNCA (encoding α-Syn), is known to play a key role in PD's pathogenesis. Several intracellular α-Syn partners, including microtubule cytoskeleton, appear to be crucial in α-Syn pathology. In human PD brains (Braak stage 6), changes in acetylated α-tubulin (AcTub) distribution are associated with α-Syn aggregate formation, suggesting that α-tubulin acetylation could trigger α-Syn aggregation. However, the longitudinal interplay between α-Syn and AcTub remains underexplored. This study aims to characterize α-Syn/AcTub interplay in the nigrostriatal and mesolimbic dopaminergic circuits of a PD mouse model at different stages of disease progression (i.e., 8 and 13 months). Specifically, we exploited two mouse lines, namely the C57BL/6JOlaHsd and the SYN120 transgenic line. The first spontaneously lacks the mSNCA gene; the latter expresses a mutant, truncated, and pro-aggregating form of human α-Syn under the tyrosine hydroxylase (TH) promoter in an α-Syn null background, mimicking key features of PD pathology. Through immunofluorescence coupled with advanced confocal microscopy analysis, we describe that the relationship between AcTub and α-Syn may be region-specific, with the SN being particularly susceptible to AcTub redistribution, with consequent changes in AcTub/α-Syn co-occurrence, while in the VTA their interplay appears to be influenced mainly by a reduction of α-Syn signal. A similar regional effect is evident at the axonal terminals, with the dorsomedial striatum and Nucleus Accumbens Core displaying more pronounced alterations in AcTub/α-Syn co-occurrence compared to the dorsolateral striatum and Nucleus Accumbens Shell. Our results indicate that early rearrangement of AcTub occurs in nigrostriatal dopaminergic neurons but not in mesolimbic ones. Moreover, the α-Syn/AcTub interplay in the SYN120 mouse model points to a nucleus-specific effect of the aggregation-prone truncated α-Syn, which appears to be further modulated by age.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
OC15 | EXPLORING Α-SYNUCLEIN/ACETYLATED Α-TUBULIN INTERPLAY ACROSS DOPAMINERGIC CIRCUITS IN A MOUSE MODEL OF PARKINSON’S DISEASE: M. Tricco1, B. Bonaldo1, A. Pianta1, G. Faustini2, A. Bellucci2, G. Cappelletti1 | 1Department of Biosciences, Università degli Studi di Milano, Italy; 2Department of Molecular and Translational Medicine, University of Brescia, Italy. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 20];70(s2). Available from: https://www.ejh.it/ejh/article/view/4809